Nicole Tasker
Obstetrics & Gynecology · Chicago, ILNPI 1649781204
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 67.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $40,700 and has fallen 86.7% since, to $5,400 in 2025. Among obstetrics & gynecology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 330 payments — averaging $380.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$85K
- Eisai Inc.$27K
- AbbVie$6K
- Immunogen, Inc.$5K
- Foundation Medicine, Inc.$801
- Merck$520
- plus $1K from 8 others
What the payments were for
- Consulting fees$9,7618%
- Speaking & faculty fees$72,97558%
- Travel & lodging$33,19926%
- Food & beverage$9,4368%
- Education$930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 163 | $85,215 |
| Eisai Inc. | 89 | $26,533 |
| AbbVie | 20 | $6,030 |
| Immunogen, Inc. | 6 | $5,211 |
| Foundation Medicine, Inc. | 15 | $801 |
| Merck | 16 | $520 |
| Clovis Oncology, Inc. | 8 | $445 |
| Coherus Oncology, Inc. | 5 | $243 |
| Seagen Inc. | 2 | $164 |
| Servier Pharmaceuticals LLC | 1 | $121 |
| Myriad Genetic Laboratories, Inc. | 2 | $102 |
| Lilly USA, LLC | 1 | $30 |
| Genentech USA, Inc. | 1 | $29 |
| Amgen | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$125,464 in reported general payments places this provider in the 95th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 17 | $277 |
| Oxycodone Hcl | 18 | $143 |
| Prochlorperazine Maleate | 21 | $143 |
| Ondansetron Hcl | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Chicago
- Lee ShulmanChicago$559K
- Maria TamChicago$378K
- Gregory UrsinoChicago$242K
- Ayman Al-HendyChicago$135K
- Teresa HubkaChicago$62K
- Magdy MiladChicago$57K
- Angela ChaudhariChicago$52K
- Carlos Sandoval-HerreraChicago$43K
- Ashlesha PatelChicago$39K
- Lemuel ShafferChicago$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.